With 80 Days To Brexit, The Three Questions To Get Your Business Ready

This year, we have all been distracted by the overwhelming challenge of COVID-19, and rightly so. Widespread disruptions, dramatically changed customer behaviour and government restrictions have hit all areas of business since the start of 2020. The pandemic has reduced companies’ cash flow and bandwidth, leaving businesses extremely vulnerable to further disruptions. With what has already been a tumultuous year, there is another serious challenge looming; Brexit. 

While preoccupied with the pandemic many businesses have seemingly forgotten about the massive effect Britain leaving the EU will have. Others are kicking the can down the road, intentionally ignoring it until the drastic change is upon them. On September 24th, The British Chamber of Commerce said that only 52% of UK firms that trade internationally had carried out a risk assessment ahead of the end of the Brexit transition period on 1 January 2021. 

With less than

Read More

The Week Ahead: A Brexit Showdown, U.S Politics, and Economic Data in Focus

On the Macro

It’s a busy week ahead on the economic calendar, with 68 stats in focus in the week ending 16th October. In the week prior, 53 stats had been in focus.

For the Dollar:

It’s a relatively busy week ahead on the economic data front.

On Monday and Tuesday, September inflation and wholesale inflation figures are due out.

The focus then shifts to manufacturing sector activity and labor market numbers on Thursday.

Expect the Philly FED Manufacturing PMI for October and the weekly initial jobless claims to impact.

At the end of the week, retail sales and industrial production figures are due out, along with October consumer sentiment numbers.

Expect the retail sales and prelim Michigan consumer Sentiment figures to have the greatest impact.

Away from the calendar, the next Presidential debate on 15th October will also provide direction. That is assuming that Trump decides to

Read More

Brexit: Pharmaceutical companies stockpiling medicine for Northern Ireland

  • Pharmaceutical companies are stockpiling medicines due to ongoing uncertainty over what will happen in Northern Ireland after Brexit.
  • The UK government last month threatened to rip up its Brexit withdrawal agreement with the EU and has warned that no trade deal may be agreed with the EU by the end of the year.
  • As a result, the industry says they “just don’t know” whether there will need to be checks on medicine going from Great Britain to Northern Ireland from next year.
  • “We just don’t know how it’ll work in Northern Ireland,” the ABPI’s Richard Torbett told Business Insider.
  • Visit Business Insider’s homepage for more stories.

Pharmaceutical companies are building up stockpiles of medicines to supply Northern Ireland due to widespread industry uncertainty over whether medicines will be allowed to move smoothly across the Irish Sea after Brexit.

With less than three months until the Brexit transition period ends, the

Read More